CN102727699A - Externally used drug for treating rheumatic arthritis - Google Patents
Externally used drug for treating rheumatic arthritis Download PDFInfo
- Publication number
- CN102727699A CN102727699A CN2012102427888A CN201210242788A CN102727699A CN 102727699 A CN102727699 A CN 102727699A CN 2012102427888 A CN2012102427888 A CN 2012102427888A CN 201210242788 A CN201210242788 A CN 201210242788A CN 102727699 A CN102727699 A CN 102727699A
- Authority
- CN
- China
- Prior art keywords
- rheumatic arthritis
- medicine
- treating
- externally used
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to an externally used drug for treating rheumatic arthritis, which is a tincture product obtained by a conventional percolation method through taking selected and washed clematis root, licorice root, dragon blood and angelica sinensis to mix uniformly, crushing into medicine powder of 100-120 meshes and then adding into white spirit with the alcohol content of 50-60%. The drug has a function of dispelling wind and removing obstruction in the meridians, activating blood and alleviating pain; the curative effect on treating the rheumatic arthritis is obvious, and the cost is low.
Description
Technical field
The present invention relates to a kind of external used medicine of treating rheumatic arthritis, especially relating to a kind of is the external used medicine of the treatment rheumatic arthritis of crude drug preparation with Chinese medicine.
Background technology
Rheumatic arthritis is one of main performance of rheumatic fever, belongs to allergic disease, and the cardinal symptom of rheumatic arthritis is that joint, the whole body, muscle the. fugitive are miserable, heavily outstanding, pain; Especially with knee joint, elbow, wrist; Joints such as omoplate are main, simultaneously also can be with the fever symptom.The prolonged and repeated outbreak of rheumatic arthritis can cause cardiorenal disease, increases the weight of rheumatisant's misery.
At present anti-inflammation analgesic and hormone medicine are adopted in the treatment of rheumatic arthritis more, this type of medicine is cured the symptoms, not the disease, and it is big to obey side effect for a long time.
Summary of the invention
The purpose of this invention is to provide a kind of is the external used medicine of the treatment rheumatic arthritis of crude drug preparation with Chinese medicine, and this medicine is the principle treatment with dispelling wind and removing obstruction in the collateral, promoting blood circulation and stopping pain, and good to the therapeutic effect of rheumatic arthritis, expense is low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Clematidis 40～60 Radix Glycyrrhizaes 40～60
Sanguis Draxonis 3～6 Radix Angelicae Sinensis 40～60.
The medicine of above-mentioned each component can be processed said exterior-applied formulation on any pharmaceuticss such as tincture, unguentum, powder, liniment, medicated wine, and the preferred dosage form of the present invention is a tincture.
The concrete method for preparing of medicinal tincture of the present invention is: said medicine is pressed said parts by weight mix homogeneously; Be ground into 100～120 purpose medicated powder; Add in the Chinese liquor of the ethanol content 50%～60% that is equivalent to 8～10 times of above-mentioned medicated powder gross weights, by the tincture product of conventional percolation legal system.
The traditional Chinese medical science thinks how rheumatic arthritis invades human body by wind-cold damp pathogen gas in an opponent's defence, or have intrinsic heat, the heat-transformation of a specified duration of wind and cold damp-stagnancy, the passages through which vital energy circulates of being detained, inaccessible obstructed forming.In the prescription of the present invention, Radix Clematidis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; The Radix Glycyrrhizae heat-clearing and toxic substances removing, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription; The Sanguis Draxonis blood activating and promoting tissue regeneration; Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving.All medicines share, and can play the effect of dispelling wind and removing obstruction in the collateral, promoting blood circulation and stopping pain, and are evident in efficacy to treatment rheumatic arthritis, and cheap.
For further investigating the clinical efficacy of Drug therapy rheumatic arthritis of the present invention, select 50 routine rheumatic arthritis patients to carry out clinical observation on the therapeutic effect.
Be divided into treatment group and matched group to 50 routine patients, 30 people are organized in treatment, matched group 20 people.
All case is all according to the diagnosis basis in " new Chinese medicine clinical research guideline (first volume) ":
(1) clinical manifestation: the streptococcal infection medical history is arranged more; Acute stage, can have multiple and the the. fugitive joint aches, mostly occurs in big joint, can be with redness pain or tuberosity or erythema; Chronic phase, can only be felt joint aches;
(2) laboratory examination: anti-" O " is more than 1:500; Or erythrocyte sedimentation rate speeds; Or antistreptokinase surpasses more than 80 units; Or antihyaluronidase is more than 128 units; Or C reflection protein positive;
(3) X-ray film does not have the sclerotin damage; Be diagnosed as rheumatic arthritis.
Therapeutic Method
Matched group adopts ibuprofen, every day 1 time, one time 2;
The treatment group adopts tincture dose medicament of the present invention, uses medicine wiping of the present invention affected part, every day 3-6 time.
Criterion of therapeutical effect
Criterion of therapeutical effect with reference to " new Chinese medicine clinical research guideline (first volume) ".Cure: the arthralgia of getting involved after the treatment disappears, and function of joint is improved or recovered normal, and it is normal that erythrocyte sedimentation rate, rheumatoid factor have been recovered; Produce effects: the arthralgia of getting involved is clearly better or disappears, and erythrocyte sedimentation rate, rheumatoid factor titre reduce, or has recovered normal, but arthroncus does not disappear as yet; Effectively: the arthralgia of getting involved after the treatment or swell and ache and take a favorable turn; Invalid: with compare each side and do not have progress before the treatment.
Two groups of case treatment back curative effect comparative results are seen table 1.
Table 1 liang group case treatment back curative effect relatively.
| Group | The example number | Cure n (%) | Produce effects n (%) | Effective n (%) | Invalid n (%) | Total effective rate n (%) |
| Matched group | 20 | 2（10） | 1（5） | 10（50） | ?7（35） | 13（65） |
| The treatment group | 30 | 12（40） | 3（10） | 12（40） | 3（10） | 27（90） |
The specific embodiment
Embodiment 1
Get Radix Clematidis 40g, Radix Glycyrrhizae 40g, Sanguis Draxonis 3g, Radix Angelicae Sinensis 40g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 purpose medicated powder, add in the Chinese liquor of 984g ethanol content 50%～60%, by the tincture product of conventional percolation legal system.
Embodiment 2
Get Radix Clematidis 60g, Radix Glycyrrhizae 60g, Sanguis Draxonis 6g, Radix Angelicae Sinensis 60g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 purpose medicated powder, add in the Chinese liquor of 1860g ethanol content 50%～60%, by the tincture product of conventional percolation legal system.
Claims (2)
1. external used medicine of treating rheumatic arthritis is that crude drug prepares by the Chinese medicine of following portions by weight:
Radix Clematidis 40～60 Radix Glycyrrhizaes 40～60
Sanguis Draxonis 3～6 Radix Angelicae Sinensis 40～60.
2. the external used medicine of treatment rheumatic arthritis according to claim 1 is characterized in that said medicine is processed tincture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102427888A CN102727699A (en) | 2012-07-14 | 2012-07-14 | Externally used drug for treating rheumatic arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102427888A CN102727699A (en) | 2012-07-14 | 2012-07-14 | Externally used drug for treating rheumatic arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102727699A true CN102727699A (en) | 2012-10-17 |
Family
ID=46984463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102427888A Pending CN102727699A (en) | 2012-07-14 | 2012-07-14 | Externally used drug for treating rheumatic arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727699A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111700961A (en) * | 2020-06-04 | 2020-09-25 | 刘关良 | Medicine for treating rheumatic ostealgia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
| CN101129676A (en) * | 2007-09-06 | 2008-02-27 | 杨恒 | Externally used plaster for treating bone disease and method of preparing the same |
| CN102475868A (en) * | 2010-11-26 | 2012-05-30 | 杨丽文 | Anti-rheumatism medicinal liquor |
-
2012
- 2012-07-14 CN CN2012102427888A patent/CN102727699A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
| CN101129676A (en) * | 2007-09-06 | 2008-02-27 | 杨恒 | Externally used plaster for treating bone disease and method of preparing the same |
| CN102475868A (en) * | 2010-11-26 | 2012-05-30 | 杨丽文 | Anti-rheumatism medicinal liquor |
Non-Patent Citations (1)
| Title |
|---|
| 高海涛等: "中医药治疗类风湿性关节炎研究进展", 《现代中医药》, no. 02, 25 March 2005 (2005-03-25) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111700961A (en) * | 2020-06-04 | 2020-09-25 | 刘关良 | Medicine for treating rheumatic ostealgia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614389B (en) | Traditional Chinese medicine patch | |
| CN102247581B (en) | Medicament for treating myoma of uterus | |
| CN102940865A (en) | Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN103054965A (en) | External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102940693B (en) | Medicine composition for treating diabetic foot | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN101991794A (en) | Chinese traditional medicine preparation for treating eczema | |
| CN103961671A (en) | Chili-wild pepper-pepper rheumatism pain relieving solution | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN103479970A (en) | External medicine for treating rheumatic arthralgia | |
| CN103735821B (en) | A kind of composite medical ointment for the treatment of acne | |
| CN103845388A (en) | Traditional Chinese medicine for treating chronic peritonitis | |
| CN102727699A (en) | Externally used drug for treating rheumatic arthritis | |
| CN103272028B (en) | A kind of medicine for the treatment of traumatic injury and rheumatic arthralgia | |
| CN101172129A (en) | Traditional Chinese medicine composition for treating hypodermal ecchymosis and method of preparing the same | |
| CN104189273A (en) | Traditional Chinese medicine used for treating thrombophlebitis | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN104225056A (en) | Drug for treating rheumatic arthritis | |
| CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
| CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
| CN101244138B (en) | Externally used traditional Chinese medicine preparation for treating frostbite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121017 |